Financials in USD. Standardized financial statements.
A compact view of how Targeted Medical Pharma, Inc. turns revenue into operating income and net income.
| Metric | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $5.26M | $7.11M | $9.56M | $7.30M | $8.81M | $7.62M | $12.20M | $12.16M |
| Revenue Growth? | -26.0% | -25.6% | +31.0% | -17.2% | +15.6% | -37.5% | +0.3% | 0.0% |
| Cost of Revenue? | $2.10M | $2.22M | $2.99M | $3.20M | $2.76M | $2.57M | $1.47M | $2.12M |
| Gross Profit? | $3.17M | $4.90M | $6.57M | $4.10M | $6.05M | $5.05M | $10.73M | $10.04M |
| Gross Margin? | +60.2% | +68.8% | +68.7% | +56.1% | +68.7% | +66.3% | +88.0% | +82.6% |
| Operating Expenses? | $5.20M | $7.51M | $10.41M | $10.23M | $11.83M | $6.63M | $4.97M | $5.39M |
| Operating Income? | -$2.03M | -$2.61M | -$3.84M | -$6.14M | -$5.78M | -$1.58M | $5.76M | $4.65M |
| EBITDA? | -$1.66M | -$2.20M | -$3.43M | -$10.14M | -$5.32M | -$1.25M | $5.88M | $4.73M |
| Income Before Tax | -$3.07M | -$3.83M | -$3.67M | -$12.77M | -$6.65M | -$838,517 | $5.77M | $4.66M |
| Income Tax Expense | $0 | $65,828 | $5.67M | -$3.19M | -$2.47M | -$4.09M | $1.78M | $1.26M |
| Net Income? | -$3.04M | -$3.90M | -$9.34M | -$9.59M | -$4.18M | $3.25M | $3.98M | $3.39M |
| EPS? | $-0.11 | $-0.15 | $-0.39 | $-0.43 | $-0.19 | $0.15 | $0.18 | $0.15 |
| Diluted EPS? | $-0.11 | $-0.15 | $-0.39 | $-0.43 | $-0.19 | $0.15 | $0.18 | $0.15 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality